by webmaster | Aug 6, 2026 | Generic & Biosimilar Insights
Medicine supply chains have become increasingly interconnected, linking manufacturers, raw material suppliers, logistics providers, regulators, and healthcare systems across multiple countries. While this global network has enabled access to a wide range of medicines,...
by webmaster | Jul 29, 2026 | Generic & Biosimilar Insights
The approval of a medicine by a regulatory authority is often viewed as the final step before it becomes available to patients. In reality, regulatory approval marks the beginning of a much longer process of oversight and monitoring that continues throughout the life...
by webmaster | Jul 23, 2026 | Generic & Biosimilar Insights
Chronic diseases continue to represent one of the most significant healthcare challenges globally and within South Africa. Conditions such as diabetes, hypertension, cardiovascular disease, asthma, chronic respiratory illnesses, autoimmune disorders, and certain...
by webmaster | Jul 16, 2026 | Generic & Biosimilar Insights
Every medicine follows a carefully monitored journey from the starting point in manufacturing to patient use. Behind the scenes, a network of quality systems, traceability processes, and safety monitoring methods work together to ensure that medicines remain safe,...
by webmaster | Jul 1, 2026 | Generic & Biosimilar Insights
Biosimilars have become an increasingly important part of modern healthcare, particularly as healthcare systems seek to expand access to advanced therapies while maintaining sustainable treatment pathways. Although often discussed alongside generic medicines,...
